What is the Astrazeneca Pharma India Ltd FII shareholding?

Foreign Institutional Investors (FIIs) hold 2.64% of the total equity shares of Astrazeneca Pharma India Ltd.

What is the Astrazeneca Pharma India Ltd DII shareholding?

Domestic Institutional Investors (DIIs) hold 7.09% of the total equity shares of Astrazeneca Pharma India Ltd.

How has the Astrazeneca Pharma India Ltd promoter holding changed?

The promoter holding in Astrazeneca Pharma India Ltd changed from 75.00% to 75.00% during the latest reported period.

How has the Astrazeneca Pharma India Ltd FII holding changed?

The FII holding in Astrazeneca Pharma India Ltd changed from 2.68% to 2.64% during the latest reported period.

How has the Astrazeneca Pharma India Ltd DII holding changed?

The DII holding in Astrazeneca Pharma India Ltd changed from 6.08% to 7.09% during the latest reported period.

Who are the major shareholders of Astrazeneca Pharma India Ltd?

The major shareholders of Astrazeneca Pharma India Ltd may include promoters, institutional investors and other significant shareholders holding substantial equity stakes.

Astrazeneca Pharma India Ltd Shareholding Pattern: Promoters, FII, DII & Public

Q: What is the Astrazeneca Pharma India Ltd public shareholding?

Public shareholders hold 15.27% of the total equity shares of Astrazeneca Pharma India Ltd as per the latest available data.

Astrazeneca Pharma India Ltd Share Price

Detail Overview

Pharmaceuticals - MultinationalNSE

₹5,988.50

-112.50(-1.84%)

As on 23 Oct 2026 at 15:50

As of 23 Oct 2026 at 15:50, Astrazeneca Pharma India Ltd is trading at ₹5,988.50. The 52-week range stands at ₹5,640.00–₹9,849.50, with a market cap of ₹14.97 thousand crore. At a P/E of 86.30 and a dividend yield of 0.60%, it is a mid-cap stock in the Pharmaceuticals sector.